| This week's sponsor is Premier Research. | | | Tips for Achieving the Most Success in Acute-Pain Drug Trials
Sponsors studying treatments for acute pain boost their odds of success when they optimize conduct of early trials. Read our white paper for helpful tips on study design, assessment, and operations. Premier Research. It's what we do. Best. |
Featured Story | | | Friday, September 15, 2017 Bavarian Nordic’s repeatedly delayed phase 3 cancer vaccine trial has come crashing to a halt. The data monitoring committee ended the six-year odyssey after ruling it would be futile to keep treating patients with the Bristol-Myers Squibb-partnered Prostvac. |
|
|
| This week's sponsor is Fierce Innovation Awards. | | | Now Accepting Applications! Deadline: Friday, October 20th
Does your product/service have the potential to transform the biotech or pharma industry? This is your chance to submit an application and have your solution reviewed by our expert panel of judges. Apply today! |
Top Stories Friday, September 15, 2017 In a phase 2 atopic dermatitis trial, Eli Lilly and Incyte's baricitinib hit its primary endpoint but missed a secondary objective, prompting unfavorable comparisons with Sanofi and Regeneron's recently approved Dupixent. Friday, September 15, 2017 Mustang Bio has picked up the rights to a CD20-directed CAR-T therapy from Fred Hutchinson Cancer Research Center. The agreement gives the Fortress Biotech offshoot a phase 1/2-ready cell therapy to advance alongside its existing clutch of CAR-Ts. Monday, September 11, 2017 When it comes to healthcare we know that consumers actively participate in social media to seek information and find support. More than 40% say that information from social media affects how they cope with a chronic condition, their approach to diet and exercise, the physician they select and even their decision to seek a second opinion1. Thursday, September 14, 2017 In a first, the FDA has approved a mobile app for use in the treatment of substance-use disorders. The Pear Therapeutics app delivers cognitive behavioral therapy to help patients abstain from substance abuse and stay in outpatient support programs. Friday, September 15, 2017 As challengers to Roche’s cancer blockbusters advance in the U.S. and around the world, Samsung Bioepis has taken a big step toward approval for a Herceptin biosim in Europe. A drug panel there recommended the proposed biosim, Ontruzant, creating a potential near-term threat to billions of Roche sales on the continent. Thursday, September 14, 2017 In this week's EuroBiotech Report, Roche, Onxeo swing and miss in phase 3, Erytech outlines first-line plans and more. Friday, September 15, 2017 WuXi NextCODE has raised $240 million in a series B to build its genomics business, FDA slapped Pfizer's partner Celltrion with a 12-observation Form 483, Biocon's $275 million insulin plant in Malaysia opened shop and more. Friday, September 15, 2017 Lundbeck chief Kåre Schultz will be paid a $52 million package to helm Teva, former CDC director Tom Frieden is leading a new $225 million global health initiative, Roivant Sciences tapped Eisai and Pfizer vet Allen Waxman as its general counsel, plus more hirings, firings and retirings throughout the industry. Resources Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. 2nd Strategic Partnerships for Drug Repurposing October 26-27, 2017 | Boston, MA Compliance Certificate and Training for Life Sciences Professionals October 9 -12, 2017 | Newark, NJ CBI’s MedComm 2017 Conference October 26-27, 2017 | San Francisco, CA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA FierceBiotech Executive Summit- London October 2, 2017 | London 11th Digital Pharma East October 3-6, 2017 | Philadelphia, PA Don't Miss This Opportunity | Life Sciences Innovation Awards Application Deadline: Friday, October 20 at midnight EST Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA | 